Related Experiment Video
Updated: Aug 3, 2026
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
Tango-therapy vs physical exercise in older people with dementia; a randomized controlled trial
Lucía Bracco1, Arrate Pinto-Carral2, Linda Hillaert3
1Inserm U1093-Cognition, Action and Sensorimotor Plasticity, Faculty of Sport Sciences, University of Burgundy, 21078, Dijon, France. lucia.bracco@u-bourgogne.fr.
Background:
Dementia is a growing health concern that affects millions of people worldwide. Gait and mobility disorders are often present and represent a major risk factor for falls. The purpose of this study was to investigate the effectiveness of tango-therapy in gait speed, functional mobility, balance, falls, ability to perform activities of daily living and quality of life.
Methods:
A randomised controlled trial with 31 participants living in a specialised dementia unit, aged 65 to 93 years old, who were randomly assigned to tango group (IG) or physical exercise group (CG). The primary outcome was gait speed and Timed Up and Go test. The secondary outcomes include the Short Physical Performance Battery, the ability to perform activities of daily living (Katz Index) and quality of life (Quality of life in Alzheimer Disease). Measurements were performed at baseline, and after one and three months of training.
Results:
After 3 months, IG improved gait speed (p = 0.016), implying a statistically significant difference between groups in favour of IG (p = 0.003). CG significantly worsened the time to complete the TUG (p = 0.039). Both groups declined in their ability to perform activities of daily living, being statistically significant only in the CG (p < 0.001).
Conclusion:
Tango interventions showed efficacy in improving gait speed and in mitigating the decline in functional mobility and ADL skill capacities. Allowing older people with dementia access to non-pharmacological interventions may be a successful strategy to prevent functional decline.
Trial Registration:
Registered at ClinicalTrials.gov (ID: NCT05744011).
